These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31589272)

  • 41. Clinical Validation of R-T Estimation for CoaguChek XS INR Results.
    Richter C; Taylor J; Wright J; Fletcher B
    Ann Pharmacother; 2016 Aug; 50(8):645-8. PubMed ID: 27199494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
    Witt DM; Sadler MA; Shanahan RL; Mazzoli G; Tillman DJ
    Chest; 2005 May; 127(5):1515-22. PubMed ID: 15888822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
    Kimmel SE; Chen Z; Price M; Parker CS; Metlay JP; Christie JD; Brensinger CM; Newcomb CW; Samaha FF; Gross R
    Arch Intern Med; 2007 Feb; 167(3):229-35. PubMed ID: 17296877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of post-operative anticoagulation management in patients who have undergone On-X mechanical heart valve replacement surgery on post-discharge warfarin therapy.
    Oh EM; Lee OS; Jang BM; Park S; Cho EJ; Kim KS; Suh SY; Cho YS; Rhie SJ
    J Clin Pharm Ther; 2020 Aug; 45(4):767-773. PubMed ID: 32415738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician.
    Bungard TJ; Ritchie B; Garg S; Tsuyuki RT
    Pharmacotherapy; 2012 Feb; 32(2):112-9. PubMed ID: 22392419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of pharmacist intervention on anticoagulation management and risk for potential COVID-19 exposure during the COVID-19 pandemic.
    Lee LC; Farwig P; Kirk L; Mitchell VD; Sabatino JA; Barnes KD
    Thromb Res; 2022 Sep; 217():52-56. PubMed ID: 35868151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.
    Cryder B; Felczak M; Janociak J; Dela Pena L; Allen S; Gutierrez P
    J Clin Pharm Ther; 2011 Feb; 36(1):64-70. PubMed ID: 21198721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.
    Donovan JL; Drake JA; Whittaker P; Tran MT
    J Thromb Thrombolysis; 2006 Aug; 22(1):23-30. PubMed ID: 16786229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulation management in remote primary care.
    Nast SL; Tierney MJ; McIlwain R
    Can Fam Physician; 2005 Mar; 51(3):384-5. PubMed ID: 16926932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.
    Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
    Mannheimer B; Andersson ML; Järnbert-Pettersson H; Lindh JD
    J Thromb Haemost; 2016 Apr; 14(4):765-71. PubMed ID: 26792124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving Warfarin Management Within the Medical Home: A Health-System Approach.
    Rose AE; Robinson EN; Premo JA; Hauschild LJ; Trapskin PJ; McBride AM
    Am J Med; 2017 Mar; 130(3):365.e7-365.e12. PubMed ID: 27984006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial.
    Matchar DB; Samsa GP; Cohen SJ; Oddone EZ; Jurgelski AE
    Am J Med; 2002 Jul; 113(1):42-51. PubMed ID: 12106622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).
    Phibbs CS; Love SR; Jacobson AK; Edson R; Su P; Uyeda L; Matchar DB;
    J Gen Intern Med; 2016 Sep; 31(9):1061-7. PubMed ID: 27234663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.